Concepedia

Maria Emilia Di Francesco

ME

Statistics

Publications

32

Citations

3.5K

H-Index

25

Active since

2003

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

IRBM Science Park

The University of Texas Health Science Center at Houston

University of Messina

University of Cambridge

Maria Emilia Di Francesco is an author at The University of Texas MD Anderson Cancer Center specializing in pharmacology, oncology, and medicine.

Publications per year

2003–2024

32

Publications

32

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Jennifer R. Molina, Yuting Sun, Marina Protopopova et al. · Nature Medicine · 2018 · 951 citations · Full text

Medicine, Cancer Biology, Oncology +14

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

Timothy A. Yap, Naval Daver, Mikhila Mahendra et al. · Nature Medicine · 2023 · 377 citations

Medicine, Oncology, Pharmacology +14

Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma

Liang Zhang, Yixin Yao, Shaojun Zhang et al. · Science Translational Medicine · 2019 · 233 citations

Medicine, Oncology, Pharmacology +17

Development of Peptidomimetics with a Vinyl Sulfone Warhead as Irreversible Falcipain-2 Inhibitors

Roberta Ettari, Emanuela Nizi, Maria Emilia Di Francesco et al. · Journal of Medicinal Chemistry · 2008 · 217 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer

Kurt W. Evans, Erkan Yuca, Stephen M. Scott et al. · Cancer Research · 2021 · 157 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 32